@neuroClues raises 5 million Euros and prepares to launch its measurement solution to diagnose @neurological diseases
#Alzheimer ‘s treatment: #lecanemab soon on sale in the United States
Alzheimer’s treatment : lecanemab soon on sale in the United States Read More »
During the 15th edition of the CTAD (Clinical Trials on Alzheimer’s Disease) taking place from November 29 to December 2 of 2022 in San Francisco, USA, REGEnLIFE, a French company specialized in the research and development of innovative technologies in photo-medicine for the prevention and treatment of neurodegenerative diseases, presented the concept of its next
How to detect the warning signs of dementia using a mobile phone? An international team of scientists has examined the issue and developed a simple and cost-effective test.
How to detect the warning signs of dementia using a mobile phone Read More »
Heathrow’s ambition to deliver excellent passenger service has taken one step further as it announces its commitment to becoming the world’s first dementia friendly airport.
Heathrow commits to becoming world’s first dementia friendly airport Read More »
